DKLRF yields 181818.18% · PFE yields 6.20%● Live data
📍 DKLRF pulled ahead of the other in Year 1
Combined, DKLRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DKLRF + PFE for your $10,000?
Decklar Resources Inc. operates as an independent international oil and gas company in Nigeria and Canada. The company explores for copper, lead, and zinc deposits. It focuses on appraisal and development in the West African region. The company holds interests in the Oza Oil Field that covers an area of 20 square kilometers located onshore in the northern part of Oil Mining Lease (OML) 11 in Nigeria's Eastern Niger Delta; the Asaramatoru Field located onshore in the southern swamp section of OML 11 in the Eastern Niger Delta; and the Emohua Oil Field located onshore in the southeastern section of OML 22 in the Eastern Niger Delta. It also holds an option to acquire a 75% interest in the Holt property that covers an area of 3,687 hectares located in east of Duncan, British Columbia. It also provides funding and technical advisory services to exploration and development companies The company was formerly known as Asian Mineral Resources Limited and changed its name to Decklar Resources Inc. in September 2020. Decklar Resources Inc. was incorporated in 2004 and is based in Toronto, Canada.
Full DKLRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.